CN Stock MarketDetailed Quotes

300119 Tianjin Ringpu Bio-Technology

Watchlist
  • 14.46
  • +0.01+0.07%
Market Closed Jun 7 15:00 CST
6.74BMarket Cap14.67P/E (TTM)

Tianjin Ringpu Bio-Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
20.42%533.2M
7.90%2.25B
7.48%1.59B
9.44%994.1M
13.30%442.78M
3.84%2.08B
-1.48%1.48B
-12.72%908.34M
-30.20%390.81M
0.34%2.01B
Operating revenue
20.42%533.2M
7.90%2.25B
7.48%1.59B
9.44%994.1M
13.30%442.78M
3.84%2.08B
-1.48%1.48B
-12.72%908.34M
-30.20%390.81M
0.34%2.01B
Other operating revenue
----
12.29%24.08M
----
-0.26%8.03M
----
6.00%21.44M
----
-25.11%8.05M
----
25.70%20.23M
Total operating cost
20.47%435.87M
8.22%1.87B
8.17%1.31B
9.02%823.89M
15.39%361.81M
4.84%1.73B
4.09%1.22B
-5.70%755.69M
-25.05%313.57M
3.48%1.65B
Operating cost
28.40%278.73M
5.29%1.13B
0.83%778.54M
1.84%477.38M
9.77%217.07M
11.09%1.07B
7.63%772.16M
-4.31%468.74M
-25.20%197.75M
5.22%967.37M
Operating tax surcharges
13.41%4.18M
8.84%22.2M
15.88%15.14M
10.54%10.24M
24.48%3.69M
7.51%20.4M
1.40%13.07M
-3.98%9.26M
-27.68%2.96M
2.89%18.97M
Operating expense
1.56%71.29M
7.81%370.96M
8.60%266.62M
9.07%176.39M
16.23%70.19M
-9.19%344.07M
7.57%245.51M
-2.90%161.73M
-29.91%60.39M
6.33%378.88M
Administration expense
19.33%40.18M
10.47%157.78M
17.39%115.57M
23.09%73.6M
16.99%33.67M
-4.97%142.82M
-8.59%98.45M
-16.98%59.8M
-18.16%28.78M
-9.00%150.28M
Financial expense
-1.19%5.07M
9.18%18.94M
24.88%14.34M
37.98%9.29M
140.15%5.13M
-7.65%17.35M
-24.78%11.48M
-30.74%6.73M
-51.25%2.14M
-26.50%18.78M
-Interest expense (Financial expense)
-0.07%6.35M
-14.45%24.33M
-12.73%18.36M
-6.51%12.31M
15.07%6.35M
19.36%28.43M
22.47%21.04M
23.21%13.17M
19.47%5.52M
-12.34%23.82M
-Interest Income (Financial expense)
10.27%-1.36M
49.87%-5.61M
55.98%-4.13M
55.09%-2.94M
56.72%-1.52M
-92.97%-11.2M
-283.68%-9.39M
-371.58%-6.55M
-743.11%-3.51M
-72.23%-5.8M
Research and development
13.60%36.42M
30.35%172.94M
66.84%124.18M
55.73%76.99M
48.77%32.06M
12.74%132.68M
-13.22%74.43M
-7.75%49.44M
-10.87%21.55M
5.52%117.69M
Credit Impairment Loss
-19.86%-5.54M
-54.60%-28.98M
-19.34%-21.45M
14.01%-9.12M
38.85%-4.62M
7.97%-18.74M
-0.65%-17.98M
24.42%-10.6M
31.67%-7.56M
32.96%-20.37M
Asset Impairment Loss
-88.35%63.09K
22.54%580.19K
-26.17%934.21K
46.63%772.15K
119.99%541.39K
155.53%473.47K
199.15%1.27M
215.91%526.61K
154.16%246.1K
-4.25%-852.63K
Other net revenue
-54.21%8.04M
196.33%190.6M
134.49%53.95M
183.26%45.68M
136.71%17.57M
-55.40%64.32M
-20.92%23.01M
1.87%16.13M
-35.78%7.42M
32.16%144.2M
Fair value change income
-31.05%10.18M
19.22%61.26M
61.69%29.78M
101.70%21.96M
78.83%14.76M
-54.85%51.38M
120.79%18.42M
69.55%10.89M
135.81%8.26M
-2.53%113.8M
Invest income
110.29%30.95K
274.01%15.15M
1,376.79%23.6M
775.40%21.39M
-138.78%-300.77K
-78.06%4.05M
-88.74%1.6M
-82.06%2.44M
-94.26%775.52K
1,121.16%18.47M
-Including: Investment income associates
75.30%-88.61K
2,477.86%21.35M
1,974.61%23.43M
30,948.85%21.31M
-19.53%-358.77K
-81.52%828.4K
-610.92%-1.25M
122.28%68.64K
-30.05%-300.16K
294.10%4.48M
Asset deal income
---716.85
1,633,310.00%114.09M
81.78%137.38K
--76.7K
----
-107.11%-6.99K
-25.72%75.58K
----
----
639.51%98.22K
Other revenue
-53.88%3.31M
4.93%28.5M
6.75%20.95M
-17.67%10.6M
25.94%7.19M
-17.83%27.16M
-17.87%19.63M
26.58%12.87M
-4.14%5.71M
49.78%33.06M
Operating profit
6.94%105.38M
35.66%565.23M
14.77%326.72M
27.92%215.89M
16.39%98.53M
-16.57%416.64M
-21.09%284.67M
-33.85%168.77M
-44.70%84.66M
-2.68%499.36M
Add:Non operating Income
244.82%369.73K
-13.58%2.96M
-84.34%489.38K
-95.61%115.51K
-92.63%107.22K
14.98%3.42M
155.62%3.12M
1,990.27%2.63M
1,880.92%1.46M
224.15%2.98M
Less:Non operating expense
45.52%666.68K
-75.86%1.51M
-60.73%1.12M
-59.71%899.43K
-23.59%458.15K
-57.04%6.25M
-13.58%2.86M
21.68%2.23M
1.96%599.62K
366.06%14.55M
Total profit
7.02%105.08M
36.94%566.68M
14.44%326.09M
27.15%215.11M
14.81%98.18M
-15.17%413.81M
-20.55%284.93M
-33.25%169.17M
-43.96%85.52M
-4.53%487.79M
Less:Income tax cost
8.36%11.57M
39.01%55.66M
7.84%31.18M
38.80%21.63M
80.18%10.68M
-26.12%40.04M
-25.56%28.92M
-46.15%15.59M
-72.92%5.93M
-24.12%54.2M
Net profit
6.86%93.5M
36.72%511.02M
15.19%294.9M
25.97%193.47M
9.94%87.5M
-13.80%373.77M
-19.94%256.02M
-31.58%153.59M
-39.11%79.59M
-1.34%433.59M
Net profit from continuing operation
6.86%93.5M
36.72%511.02M
15.19%294.9M
25.97%193.47M
9.94%87.5M
-13.80%373.77M
-19.94%256.02M
-31.58%153.59M
-39.11%79.59M
-1.34%433.59M
Less:Minority Profit
-11.17%5.93M
114.53%58.07M
-7.79%21.2M
10.52%15.2M
-9.53%6.68M
30.12%27.07M
-16.71%23M
-34.20%13.76M
-48.55%7.38M
-49.62%20.81M
Net profit of parent company owners
8.35%87.57M
30.64%452.94M
17.46%273.7M
27.49%178.27M
11.93%80.82M
-16.01%346.7M
-20.25%233.02M
-31.32%139.83M
-37.94%72.21M
3.66%412.78M
Earning per share
Basic earning per share
9.13%0.1901
30.50%0.9772
17.16%0.59
27.00%0.3843
11.38%0.1742
-27.00%0.7488
-31.56%0.5036
-40.98%0.3026
-46.62%0.1564
2.02%1.0258
Diluted earning per share
9.13%0.1901
30.50%0.9772
17.16%0.59
27.00%0.3843
11.38%0.1742
-27.00%0.7488
-31.56%0.5036
-40.98%0.3026
-46.62%0.1564
2.02%1.0258
Other composite income
Total composite income
6.86%93.5M
36.72%511.02M
15.19%294.9M
25.97%193.47M
9.94%87.5M
-13.80%373.77M
-19.94%256.02M
-31.58%153.59M
-39.11%79.59M
-1.34%433.59M
Total composite income of parent company owners
8.35%87.57M
30.64%452.94M
17.46%273.7M
27.49%178.27M
11.93%80.82M
-16.01%346.7M
-20.25%233.02M
-31.32%139.83M
-37.94%72.21M
3.66%412.78M
Total composite income of minority owners
-11.17%5.93M
114.53%58.07M
-7.79%21.2M
10.52%15.2M
-9.53%6.68M
30.12%27.07M
-16.71%23M
-34.20%13.76M
-48.55%7.38M
-49.62%20.81M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 20.42%533.2M7.90%2.25B7.48%1.59B9.44%994.1M13.30%442.78M3.84%2.08B-1.48%1.48B-12.72%908.34M-30.20%390.81M0.34%2.01B
Operating revenue 20.42%533.2M7.90%2.25B7.48%1.59B9.44%994.1M13.30%442.78M3.84%2.08B-1.48%1.48B-12.72%908.34M-30.20%390.81M0.34%2.01B
Other operating revenue ----12.29%24.08M-----0.26%8.03M----6.00%21.44M-----25.11%8.05M----25.70%20.23M
Total operating cost 20.47%435.87M8.22%1.87B8.17%1.31B9.02%823.89M15.39%361.81M4.84%1.73B4.09%1.22B-5.70%755.69M-25.05%313.57M3.48%1.65B
Operating cost 28.40%278.73M5.29%1.13B0.83%778.54M1.84%477.38M9.77%217.07M11.09%1.07B7.63%772.16M-4.31%468.74M-25.20%197.75M5.22%967.37M
Operating tax surcharges 13.41%4.18M8.84%22.2M15.88%15.14M10.54%10.24M24.48%3.69M7.51%20.4M1.40%13.07M-3.98%9.26M-27.68%2.96M2.89%18.97M
Operating expense 1.56%71.29M7.81%370.96M8.60%266.62M9.07%176.39M16.23%70.19M-9.19%344.07M7.57%245.51M-2.90%161.73M-29.91%60.39M6.33%378.88M
Administration expense 19.33%40.18M10.47%157.78M17.39%115.57M23.09%73.6M16.99%33.67M-4.97%142.82M-8.59%98.45M-16.98%59.8M-18.16%28.78M-9.00%150.28M
Financial expense -1.19%5.07M9.18%18.94M24.88%14.34M37.98%9.29M140.15%5.13M-7.65%17.35M-24.78%11.48M-30.74%6.73M-51.25%2.14M-26.50%18.78M
-Interest expense (Financial expense) -0.07%6.35M-14.45%24.33M-12.73%18.36M-6.51%12.31M15.07%6.35M19.36%28.43M22.47%21.04M23.21%13.17M19.47%5.52M-12.34%23.82M
-Interest Income (Financial expense) 10.27%-1.36M49.87%-5.61M55.98%-4.13M55.09%-2.94M56.72%-1.52M-92.97%-11.2M-283.68%-9.39M-371.58%-6.55M-743.11%-3.51M-72.23%-5.8M
Research and development 13.60%36.42M30.35%172.94M66.84%124.18M55.73%76.99M48.77%32.06M12.74%132.68M-13.22%74.43M-7.75%49.44M-10.87%21.55M5.52%117.69M
Credit Impairment Loss -19.86%-5.54M-54.60%-28.98M-19.34%-21.45M14.01%-9.12M38.85%-4.62M7.97%-18.74M-0.65%-17.98M24.42%-10.6M31.67%-7.56M32.96%-20.37M
Asset Impairment Loss -88.35%63.09K22.54%580.19K-26.17%934.21K46.63%772.15K119.99%541.39K155.53%473.47K199.15%1.27M215.91%526.61K154.16%246.1K-4.25%-852.63K
Other net revenue -54.21%8.04M196.33%190.6M134.49%53.95M183.26%45.68M136.71%17.57M-55.40%64.32M-20.92%23.01M1.87%16.13M-35.78%7.42M32.16%144.2M
Fair value change income -31.05%10.18M19.22%61.26M61.69%29.78M101.70%21.96M78.83%14.76M-54.85%51.38M120.79%18.42M69.55%10.89M135.81%8.26M-2.53%113.8M
Invest income 110.29%30.95K274.01%15.15M1,376.79%23.6M775.40%21.39M-138.78%-300.77K-78.06%4.05M-88.74%1.6M-82.06%2.44M-94.26%775.52K1,121.16%18.47M
-Including: Investment income associates 75.30%-88.61K2,477.86%21.35M1,974.61%23.43M30,948.85%21.31M-19.53%-358.77K-81.52%828.4K-610.92%-1.25M122.28%68.64K-30.05%-300.16K294.10%4.48M
Asset deal income ---716.851,633,310.00%114.09M81.78%137.38K--76.7K-----107.11%-6.99K-25.72%75.58K--------639.51%98.22K
Other revenue -53.88%3.31M4.93%28.5M6.75%20.95M-17.67%10.6M25.94%7.19M-17.83%27.16M-17.87%19.63M26.58%12.87M-4.14%5.71M49.78%33.06M
Operating profit 6.94%105.38M35.66%565.23M14.77%326.72M27.92%215.89M16.39%98.53M-16.57%416.64M-21.09%284.67M-33.85%168.77M-44.70%84.66M-2.68%499.36M
Add:Non operating Income 244.82%369.73K-13.58%2.96M-84.34%489.38K-95.61%115.51K-92.63%107.22K14.98%3.42M155.62%3.12M1,990.27%2.63M1,880.92%1.46M224.15%2.98M
Less:Non operating expense 45.52%666.68K-75.86%1.51M-60.73%1.12M-59.71%899.43K-23.59%458.15K-57.04%6.25M-13.58%2.86M21.68%2.23M1.96%599.62K366.06%14.55M
Total profit 7.02%105.08M36.94%566.68M14.44%326.09M27.15%215.11M14.81%98.18M-15.17%413.81M-20.55%284.93M-33.25%169.17M-43.96%85.52M-4.53%487.79M
Less:Income tax cost 8.36%11.57M39.01%55.66M7.84%31.18M38.80%21.63M80.18%10.68M-26.12%40.04M-25.56%28.92M-46.15%15.59M-72.92%5.93M-24.12%54.2M
Net profit 6.86%93.5M36.72%511.02M15.19%294.9M25.97%193.47M9.94%87.5M-13.80%373.77M-19.94%256.02M-31.58%153.59M-39.11%79.59M-1.34%433.59M
Net profit from continuing operation 6.86%93.5M36.72%511.02M15.19%294.9M25.97%193.47M9.94%87.5M-13.80%373.77M-19.94%256.02M-31.58%153.59M-39.11%79.59M-1.34%433.59M
Less:Minority Profit -11.17%5.93M114.53%58.07M-7.79%21.2M10.52%15.2M-9.53%6.68M30.12%27.07M-16.71%23M-34.20%13.76M-48.55%7.38M-49.62%20.81M
Net profit of parent company owners 8.35%87.57M30.64%452.94M17.46%273.7M27.49%178.27M11.93%80.82M-16.01%346.7M-20.25%233.02M-31.32%139.83M-37.94%72.21M3.66%412.78M
Earning per share
Basic earning per share 9.13%0.190130.50%0.977217.16%0.5927.00%0.384311.38%0.1742-27.00%0.7488-31.56%0.5036-40.98%0.3026-46.62%0.15642.02%1.0258
Diluted earning per share 9.13%0.190130.50%0.977217.16%0.5927.00%0.384311.38%0.1742-27.00%0.7488-31.56%0.5036-40.98%0.3026-46.62%0.15642.02%1.0258
Other composite income
Total composite income 6.86%93.5M36.72%511.02M15.19%294.9M25.97%193.47M9.94%87.5M-13.80%373.77M-19.94%256.02M-31.58%153.59M-39.11%79.59M-1.34%433.59M
Total composite income of parent company owners 8.35%87.57M30.64%452.94M17.46%273.7M27.49%178.27M11.93%80.82M-16.01%346.7M-20.25%233.02M-31.32%139.83M-37.94%72.21M3.66%412.78M
Total composite income of minority owners -11.17%5.93M114.53%58.07M-7.79%21.2M10.52%15.2M-9.53%6.68M30.12%27.07M-16.71%23M-34.20%13.76M-48.55%7.38M-49.62%20.81M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg